Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin
- PMID: 33522637
- PMCID: PMC8013483
- DOI: 10.1111/jce.14894
Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin
Comment in
-
Role for digoxin in patients hospitalized with COVID-19 and atrial arrhythmias.J Cardiovasc Electrophysiol. 2021 Mar;32(3):880-881. doi: 10.1111/jce.14901. Epub 2021 Feb 1. J Cardiovasc Electrophysiol. 2021. PMID: 33522631 Free PMC article. No abstract available.
Comment on
-
Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID-19.J Cardiovasc Electrophysiol. 2020 Dec;31(12):3077-3085. doi: 10.1111/jce.14770. Epub 2020 Oct 14. J Cardiovasc Electrophysiol. 2020. PMID: 33017083 Free PMC article.
References
-
- Workman AJ, Kane KA, Rankin AC. Characterization of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res. 2003;59:593‐602. - PubMed
-
- Prassas I, Diamandis EP. Novel therapeutic applications of cardiac glycosides. Nat Rev Drug Discov. 2008;7:926‐935. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical